Retour aux projets

17241.1 PFLS-LS

Chemical warheads targeting cancer and inflammatory disorders

Résumé

Chemical warheads targeting cancer and inflammatory disorders

Textes supplémentaires

Abstract

PIQUR and UniBas propose to co-develop a novel strategy to produce covalent inhibitors targeting PI3K/mTOR in cancer and inflammation. The project aims to equip PIQUR with currently unexplored technologyies in the PI3K/mTOR field, and allows UniBas to to study selective PI3K/mTOR-dependent disease mechanisms by Chemical Genetics. Central is entry into uncharted IP space, enlargement of the PIQUR portfolio, the implementation of a proprietary kinase targeting platform, and a highly selective validation of PI3K isoforms as pharmaceutical drug targets.

Participants

Matthias Wymann

Kontaktperson

matthias.wymann@unibas.ch

Universität Basel CHE-115.244.907 Matthias Wymann Mattenstrasse 28 4058 Basel BS CH

Doriano Fabbro

Wirtschaftspartner

doriano.fabbro@piqur.com

PIQUR Therapeutics AG Doriano Fabbro Hochbergerstrasse 60C 4057 Basel BS CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2014-11-30
Date de fin
2016-05-31
Coûts totaux approuvés
CHF 716832.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T115 Medical technology 100.0%